Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Cancer Drugs Market Research Reports

Titlepublishedprice

Global Erlotinib Hydrochloride Market Insights, Forecast to 2025

By QYResearch Group
"...... Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales c......"
15-Aug-2018$3900

Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025

By HeyReport
"...... - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - Gastrointestinal Cancer - Prostate Cancer......"
15-Aug-2018$2000

Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

By Global Info Research
"...... e. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufactu......"
14-Aug-2018$3480

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023

By Global Info Research
"...... e. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufactu......"
14-Aug-2018$4880

Global and India Capecitabine Market Research by Company, Type & Application 2013-2025

By HeyReport
"...... of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer By Company - Teva - Roche -......"
13-Aug-2018$2000

Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025

By HeyReport
"...... chrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Treatment - Ophthalmic Use - Others......"
13-Aug-2018$2000

Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025

By HeyReport
"...... s usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body Market ......"
13-Aug-2018$2000

2018-2023 Global Cancer Treatment Drugs Consumption Market Report

By LP Information INC
"...... classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others......"
10-Aug-2018$4660

Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

By Global Info Research
"...... , fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic ......"
10-Aug-2018$3480

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hydroxycarbamide Market 2018, Forecast to 2023

By Global Info Research
"...... , fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic ......"
10-Aug-2018$4880

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy